These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 21679534)

  • 1. Activated recombinant factor VIIa and uncontrolled gastrointestinal bleeding.
    Oswanski MF; Shaik I; Nazzal M; Calkins K; Stombaugh H; Lowe S
    Am Surg; 2011 Apr; 77(4):E59-61. PubMed ID: 21679534
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of recombinant activated factor VII in a patient with severe thrombocytopenia due to myelodysplastic syndrome with uncontrolled gastrointestinal bleeding.
    Ozcelik T; Ozkocaman V; Ozkalemkas F; Ali R; Altundal Y; Ozkan A; Tunali A
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):385-6. PubMed ID: 17473584
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of recombinant activated factor VII in a Jehovah's Witness patient.
    Hsieh A; Cheong I
    Am J Emerg Med; 2007 Nov; 25(9):1085.e1-2. PubMed ID: 18022514
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of gastrointestinal bleeding with recombinant factor VIIa after kidney transplantation in patients with pancytopenia.
    Malato A; Lo Monte AI; Anastasio R; Lo Coco L; Abbene I; Maione C; Gioviale MC; Siragusa S
    Transplant Proc; 2006 May; 38(4):1031-3. PubMed ID: 16757254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful management of massive gastrointestinal bleeding using recombinant factor VIIa in an elderly patient with respiratory and renal failure].
    Liu M; Wang G; Ma Q; Ren J; Guo L; Zhang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul; 34(8):1215-6. PubMed ID: 25176101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant factor VIIa: a useful tool for life-threatening colonic bleeding. Report of a case.
    Mitchell JG; Speake WJ; Russell NK; Girling K; Armitage NC
    Dis Colon Rectum; 2007 Dec; 50(12):2238-40. PubMed ID: 17917781
    [No Abstract]   [Full Text] [Related]  

  • 7. Mallory-Weiss tear: use of recombinant factor VIIa for exsanguinating bleed.
    Shah AK; Banerjee D; Gambhir RP; Chaudhry R
    Trop Gastroenterol; 2009; 30(4):226-7. PubMed ID: 20426286
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant factor VIIa for the prophylaxis of perioperative hemorrhage in a patient with congenital factor XI deficiency undergoing brain tumor neurosurgery.
    Sucker C; Sabel M; Stummer W; Zotz RB; Scharf RE; Gerhardt A
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):472-5. PubMed ID: 18160590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Post-partum hemorrhage: new therapeutic options].
    Franchini M
    Recenti Prog Med; 2007 Jan; 98(1):7-11. PubMed ID: 17345873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
    Daniloś J; Goral A; Paluszkiewicz P; Przesmycki K; Kotarski J
    Obstet Gynecol; 2003 Jun; 101(6):1172-3. PubMed ID: 12798520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage.
    Franchini M; Lippi G; Franchi M
    BJOG; 2007 Jan; 114(1):8-15. PubMed ID: 17233855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-label use of recombinant activated factor VII--safe or not safe?
    Aledort LM
    N Engl J Med; 2010 Nov; 363(19):1853-4. PubMed ID: 21047230
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of massive acute lower gastrointestinal bleeding in diverticular disease of colon, with activated recombinant factor VII (NovoSeven).
    Ali ZS; Al-Shaalan H; Jorgensen J
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):327-9. PubMed ID: 16651879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe gastrointestinal haemorrhage responding to recombinant factor VIIa in a Jehovah's Witness with refractory immune thrombocytopenia.
    Virchis A; Hughes C; Berney S
    Hematol J; 2004; 5(3):281-2. PubMed ID: 15167918
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence and desperation in off-label prescribing: recombinant factor VIIa.
    Lipworth W; Kerridge I; Little M; Day R
    BMJ; 2012 Jan; 344():d7926. PubMed ID: 22250217
    [No Abstract]   [Full Text] [Related]  

  • 16. Rectal amputation sparing by haemostatic therapy with recombinant factor VIIa in a patient with cytomegalovirus-related colitis.
    Girardis M; Marietta M; Busani S; Codeluppi M; Villa E; Pasetto A
    Thromb Haemost; 2006 Mar; 95(3):579-80. PubMed ID: 16525592
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
    Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of recombinant FVIIa for intraperitoneal coagulopathic bleeding in a septic patient.
    Holcomb JB; Neville HL; Fischer CF; Hoots K
    Curr Surg; 2003; 60(4):423-7. PubMed ID: 14972234
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM; Easley RB; Tobias JD
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined fresh frozen plasma with recombinant factor VIIa in restoring hemostasis for invasive procedures in children with liver diseases.
    Chuansumrit A; Treepongkaruna S; Phuapradit P
    Thromb Haemost; 2001 Apr; 85(4):748-9. PubMed ID: 11341519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.